Literature DB >> 10516637

Effect of pre-exposure to vasoconstrictors on isoprenaline-induced relaxation in rat aorta: involvement of inducible nitric oxide synthase.

A Eckly-Michel1, T Keravis, N Boudjemaa, C Lugnier.   

Abstract

1. The aim of this study was to determine whether a brief (30 min) episode of contractile receptor stimulation could affect the degree of a subsequent vasorelaxation. Therefore, concentration - relaxation curves of the rat aorta to isoprenaline were compared before and after exposure of the tissue to noradrenaline (100 microM) or prostaglandin F2alpha (PGF2alpha, 100 microM). 2. Exposure to noradrenaline enhanced the second maximal relaxant effect of isoprenaline (from 20 - 95% relaxation). This effect was not due to significant differences in precontraction levels and was not modified by the presence of the endothelium. Treatment with PGF2alpha mimicked the actions of noradrenaline on subsequent vasorelaxation to isoprenaline. 3. Before exposure to noradrenaline (100 microM), forskolin (10 microM) did not produce any significant relaxation of the rat aorta. After exposure to noradrenaline, forskolin caused a concentration-dependent relaxation with a maximal effect of more than 90% in rings with and without endothelium suggesting that the change in vasorelaxation to isoprenaline occurred downstream from the beta-adrenoceptor. 4. The increase in relaxation due to exposure to noradrenaline was markedly attenuated by treatment with a protein synthase inhibitor (cycloheximide), a nitric oxide (NO) synthase inhibitor (L-NG-nitroarginine methyl ester, L-NAME) and an inhibitor of the activation of soluble guanylyl cyclase (methylene blue). 5. Western blot analysis showed an increase of inducible NO synthase (iNOS) in aortic rings exposed to noradrenaline or PGF2alpha. 6. Together, these findings suggest that pretreatment of rat aorta with noradrenaline or PGF2alpha could induce vascular NOS which would in turn result in an increase in isoprenaline-induced vasorelaxation, this increase occurring downstream from receptor activation. Such a mechanism might participate in cardioprotection during preconditioning induced by noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516637      PMCID: PMC1571681          DOI: 10.1038/sj.bjp.0702840

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells.

Authors:  I Fleming; G A Gray; C Schott; J C Stoclet
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

2.  Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.

Authors:  N Komas; C Lugnier; J C Stoclet
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas.

Authors:  I Fleming; G A Gray; J C Stoclet
Journal:  Am J Physiol       Date:  1993-04

4.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.

Authors:  W Martin; R F Furchgott; G M Villani; D Jothianandan
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

5.  Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.

Authors:  D D Rees; S Cellek; R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

6.  Lack of importance of NO in beta-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries.

Authors:  M L Béa; B Ghaleh; J F Giudicelli; A Berdeaux
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

8.  Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide.

Authors:  J Graves; L Poston
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

9.  Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.

Authors:  A E Eckly; C Lugnier
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

Authors:  W M Moore; R K Webber; G M Jerome; F S Tjoeng; T P Misko; M G Currie
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.